How to optimise prostate SBRT: ESTRO clinical practice consensus recommendations

A steady rise in the number of patients receiving stereotactic body radiation therapy (SBRT) for primary prostate cancer is expected. Consequently, the current European Society for Radiotherapy and Oncology (ESTRO) ‘how to’ consensus has been developed to offer practical recommendations for the initiation and implementation of prostate SBRT in radiotherapy (RT) departments.

Why it matters: These ‘how to’ clinical practice consensus recommendations, based on the latest available evidence, are developed in cooperation with ESTRO and intended for radiation oncologists, medical physicists and RTTs to jointly implement or optimise prostate SBRT in their radiation oncology department.